Skip to content

Acadia Medical Hub

Scientific and Medical Information for Professionals

Our team is committed to providing U.S. healthcare professionals with accurate and current scientific information about Acadia products, and our research and development efforts to help address unmet medical needs.

Doctors reviewing medical information

Areas of Focus

Acadia is advancing care in neurological disorders and rare diseases with therapies that redefine options for patients and families who have few or none. Our areas of focus include Parkinson’s disease psychosis, Alzheimer’s disease psychosis, Rett syndrome and more.

Parkinson’s Disease Psychosis (PDP)

PDP is typically characterized by hallucinations and delusions. Around 50% of patients with Parkinson’s disease may experience hallucinations and/or delusions over the course of their disease.

Alzheimer’s Disease Psychosis (ADP)

Approximately 6 million people in the United States are living with Alzheimer’s disease, with this number projected to rise as the elderly population grows. Hallucinations and delusions associated with ADP affect around 30% of patients with AD dementia.

Rett Syndrome (RTT)

RTT is a rare neurodevelopmental disorder that occurs primarily in females following apparently normal development for the first 6-18 months of life. RTT occurs worldwide in approximately one of every 10,000 to 15,000 female births (6,000 to 9,000 patients in the U.S.).

Scientific Publications

In collaboration with leading experts, Acadia pursues scientific discovery in neurological disorders and rare diseases. Explore our peer-reviewed publications to learn more about the research driving our innovations.

Resources

We’re here to support the medical community in their work. Click to explore our collection of resources, from info on clinical trials to our independent medical education grants.

Members of the Acadia team in a meeting
Independent Medical Education Grants

Discover Acadia-funded grants for independent medical education.

Learn More
A dropper adding liquid to a test tube
Investigator-Initiated Studies (IIS)

Find information on Acadia-supported investigator-initiated studies.

Learn More
Clinical Trials

Discover the world of our clinical trials.

Learn More

Get in Touch

How can we help? Click here to get in touch with us directly. Our team is committed to supporting you.

To report an Adverse Event or Product Complaint please call (844) 422-2342.

Important Note

You are now being redirected

You are now leaving acadia.com

You are about to leave acadia.com. You will be redirected to a third party website not affiliated with Acadia Pharmaceuticals Inc.
Do you want to continue?

You are leaving our {{LEAVING_REGION}} website and going to our {{ENTERING_REGION}} website, which is in {{ENTERING_LANGUAGE}}.
The information you are about to be referred to may not comply with the local regulatory requirements.
Do you want to continue?

You are now being directed to another Acadia website that contains information about specific treatment(s).
Do you want to continue?

Continue